TipRanks
Tvardi Therapeutics (DE:69C)
FRANKFURT:69C

Compare Tvardi Therapeutics (69C) vs. Competitors

1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Tvardi Therapeutics
€1.39
€13.62M
-0.41
-97.16%
6 Buy
1 Hold
1 Sell
Moderate Buy
Cue Biopharma
$28.85
$185.75M
-0.95
18.62%
1 Buy
0 Hold
0 Sell
Moderate Buy
Aligos Therapeutics
$7.47
$34.59M
-0.76
-45.90%
4 Buy
0 Hold
0 Sell
Strong Buy
Genenta Science SpA Sponsored ADR
$1.02
$35.92M
-2.01
-77.48%
―
Adlai Nortye Ltd. Sponsored ADR
$13.74
$971.76M
-7.72
750.14%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:69C
Tvardi Therapeutics
0.92
-32.83
-97.27%
PSTV
―
―
―
―
CUE
Cue Biopharma
25.57
3.75
17.16%
ALGS
Aligos Therapeutics
5.54
-4.68
-45.79%
GNTA
Genenta Science SpA Sponsored ADR
0.75
-2.48
-76.86%
ANL
Adlai Nortye Ltd. Sponsored ADR
15.09
13.34
762.29%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts